| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |